В. З. Ланкин

2.4k citations

151 papers · 1.9k indexed · h-index 24

Co-authors: А. К. Тихазе Г. Г. Коновалова К. Б. Шумаев Rainer Wiesner Hartmut Kühn T Schewe J Belkner Yu. N. Belenkov
Topics: Antioxidant Activity and Oxidative Stress (43 papers)Free Radicals and Antioxidants (37 papers)Biochemical effects in animals (34 papers)
Cited by: Biochemistry Clinical Biochemistry
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Analytical Biochemistry
Partner nations: Russia United States Estonia

In The Last Decade

В. З. Ланкин

147 papers receiving 1.8k citations

Peers

Countries citing papers authored by В. З. Ланкин

Since Specialization

Citations

This map shows the geographic impact of В. З. Ланкин's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. З. Ланкин with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. З. Ланкин more than expected).

Fields of papers citing papers by В. З. Ланкин

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. З. Ланкин. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. З. Ланкин. The network helps show where В. З. Ланкин may publish in the future.

Co-authorship network of co-authors of В. З. Ланкин

This figure shows the co-authorship network connecting the top 25 collaborators of В. З. Ланкин. A scholar is included among the top collaborators of В. З. Ланкин based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. З. Ланкин. В. З. Ланкин is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of Natural Low Molecular Weight Dicarbonyls in Atherogenesis and Diabetogenesis 2024 ·Reviews in Cardiovascular Medicine ·В. З. Ланкин,А. К. Тихазе,М. Г. Шарапов,Г. Г. Коновалова	3
2	Clearance and Utilization of Dicarbonyl-Modified LDL in Monkeys and Humans 2023 ·International Journal of Molecular Sciences ·В. З. Ланкин,Г. Г. Коновалова,S.P. Domogatsky,А. К. Тихазе,(unknown),М. В. Ежов	4
3	AICAR Protects Vascular Endothelial Cells from Oxidative Injury Induced by the Long-Term Palmitate Excess 2021 ·International Journal of Molecular Sciences ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),В. З. Ланкин,Iurii Stafeev,Maxim V. Skulachev,(unknown),Alexander V. Vorotnikov,Vladimir P. Shirinsky	19
4	Hydroperoxide-Reducing Enzymes in the Regulation of Free-Radical Processes 2021 ·Biochemistry (Moscow) ·М. Г. Шарапов,Sergey V. Gudkov,В. З. Ланкин	27
5	Impact of summer heat waves on key parameters of oxidative stress in patients with coronary artery disease 2021 ·Terapevticheskii arkhiv ·(unknown),А. К. Тихазе,Г. Г. Коновалова,(unknown),T. V. Martynyuk,В. З. Ланкин	0
6	The mechanisms of cardiac protection using a synthetic agonist of galanin receptors during chronic administration of doxorubicin 2020 ·Acta Naturae ·И. М. Студнева,(unknown),(unknown),Г. Г. Коновалова,В. З. Ланкин,О. И. Писаренко	11
7	PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases 2018 ·Terapevticheskii arkhiv ·В. З. Ланкин,А. К. Тихазе,Margus Viigimaa,И Е Чазова	10
8	The interaction of superoxide radicals with active dicarbonyl compounds 2017 ·BIOPHYSICS ·К. Б. Шумаев,В. З. Ланкин,Г. Г. Коновалова,А. К. Тихазе,E. K. Ruuge	1
9	Hypoosmotic hemolysis of erythrocytes by active carbonyl forms 2017 ·BIOPHYSICS ·В. З. Ланкин,(unknown),А. К. Тихазе	0
10	LIPID PROFILE AND GENETIC MARKERS ASSOCIATED WITH THE LEVEL OF OXIDIzED LOW DENSITY LIPOPROTEIDES 2017 ·Russian Journal of Cardiology ·(unknown),А. Н. Мешков,В. З. Ланкин,(unknown),А. В. Киселева,(unknown),Anastasia A. Zharikova,А. И. Ершова,А. К. Тихазе,Е. B. Yarovaya,И Е Чазова,S. А. Boytsov	2
11	Impact of a cold wave on disease course, hemodynamics, carbohydrate metabolism, and blood rheological properties in cardiac patents 2015 ·Terapevticheskii arkhiv ·Ф. Т. Агеев,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),В. З. Ланкин,Г. Г. Коновалова,А. К. Тихазе,(unknown)	6
12	AN ADAPTOGEN USAGE IN OUTPATIENT PRACTICE TO IMPROVE CARDIOVASCULAR ADAPTATION TO ABNORMAL CLIMATIC CONDITIONS (THE HEAT) 2014 ·Russian Journal of Cardiology ·(unknown),(unknown),Ф. Т. Агеев,(unknown),(unknown),(unknown),Г. Г. Коновалова,А. К. Тихазе,В. З. Ланкин	1
13	Using Mеldonium to Improve the Adaptation of Patients With Cardiovascular Disease to the Effects of Heat and Correction of Associated Oxidative Stress 2014 ·Kardiologiia ·(unknown),(unknown),(unknown),(unknown),В. З. Ланкин,(unknown),(unknown),Ф. Т. Агеев	4
14	The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients 2014 ·Cell Biochemistry and Biophysics ·Mark A. Babizhayev,И. А. Строков,В. В. Носиков,(unknown),V. F. Sitnikov,Yegor E. Yegorov,В. З. Ланкин	118
15	Modification of lipoprotein(a) by natural dicarbonyls induced their following free radical peroxidation 2011 ·Doklady Biochemistry and Biophysics ·В. З. Ланкин,O. Afanasieva,Г. Г. Коновалова,(unknown),(unknown),А. К. Тихазе,(unknown),S. Pokrovsky	3
16	Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis 2010 ·Blood Pressure ·Margus Viigimaa,(unknown),(unknown),А. К. Тихазе,Г. Г. Коновалова,(unknown),В. З. Ланкин	39
17	Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus 2007 ·Bulletin of Experimental Biology and Medicine ·(unknown),В. З. Ланкин,Г. Г. Коновалова,А. К. Тихазе,Ф. Т. Агеев,(unknown),(unknown),Mareev VIu,Yu. N. Belenkov	10
18	Effect of β-hydroxy-β-methylglutaryl coenzyme a reductase inhibitors and antioxidant vitamins on free radical lipid oxidation in rat liver 2007 ·Bulletin of Experimental Biology and Medicine ·В. З. Ланкин,М. В. Иванова,Г. Г. Коновалова,А. К. Тихазе,(unknown),В. В. Кухарчук	10
19	Protection of Rat Myocardium by Coenzyme Q during Oxidative Stress Induced by Hydrogen Peroxide 2004 ·Biochemistry (Moscow) ·V. L. Lakomkin,Г. Г. Коновалова,Е. И. Каленикова,Irina Zabbarova,А. К. Тихазе,(unknown),В. З. Ланкин,E. K. Ruuge,V. I. Kapelko	10
20	Interaction of tocopherol with peroxyl radicals does not lead to the formation of lipid hydroperoxides in liposomes 1994 ·Chemistry and Physics of Lipids ·(unknown),М. В. Иванова,В. З. Ланкин	12

About В. З. Ланкин

В. З. Ланкин is a scholar working on Biochemistry, Clinical Biochemistry and Nutrition and Dietetics, having authored 151 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antioxidant Activity and Oxidative Stress (43 papers), Free Radicals and Antioxidants (37 papers) and Biochemical effects in animals (34 papers). The work is most often cited by research in Biochemistry (439 citations), Biochemistry (230 citations) and Clinical Biochemistry (193 citations). В. З. Ланкин has collaborated with scholars based in Russia, United States and Estonia. Frequent co-authors include А. К. Тихазе, Г. Г. Коновалова, К. Б. Шумаев, Rainer Wiesner, Hartmut Kühn, T Schewe, J Belkner, Yu. N. Belenkov, Mark A. Babizhayev and Yegor E. Yegorov. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact